B.L. Scott

7.4k citations

47 papers · 2.2k indexed · h-index 20

Impact in

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological diseases and metabolism
Cellular and Molecular Neuroscience top 5%
- Nuclear Receptors and Signaling

Papers in ⓘ

Neurology 29
- Parkinson's Disease Mechanisms and Treatments 19
- Neurological disorders and treatments 13
- Botulinum Toxin and Related Neurological Disorders 9
Cellular and Molecular Neuroscience 16
- Genetic Neurodegenerative Diseases 7

Co-authors: Nicolás G. Bazán (6 shared papers)Jeffery M. Vance (10 shared papers)Joseph Jankovic (2 shared papers)Jeffrey M. Stajich (8 shared papers)William K. Scott (8 shared papers)Eden R. Martin (6 shared papers)Mark Stacy (6 shared papers)Dana B. Hancock (3 shared papers)
Journals: Movement Disorders (4 papers)Neurology (2 papers)Proceedings of the National Academy of Sciences (2 papers)Translational Vision Science & Technology (2 papers)Ophthalmology Retina (1 paper)
Partner nations: United States Singapore United Kingdom

In The Last Decade

B.L. Scott

47 papers receiving 2.1k citations

Peers

Countries citing papers authored by B.L. Scott

Since Specialization

Citations

This map shows the geographic impact of B.L. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.L. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.L. Scott more than expected).

Fields of papers citing papers by B.L. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.L. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.L. Scott. The network helps show where B.L. Scott may publish in the future.

Co-authors

The 25 scholars most cited alongside B.L. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B.L. Scott Line = papers co-authored together B.L. Scott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease Annals of Human Genetics ·Todd L. Edwards, William K. Scott, Cherylyn Almonte, Amber Burt, Eric Powell, Gary W. Beecham, Liyong Wang, Stephan Züchner, Ioanna Konidari, Gaofeng Wang, Carlos Singer, Fatta B. Nahab, B.L. Scott, Jeffrey M. Stajich, Margaret A. Pericak‐Vance, Jonathan L. Haines, Jeffery M. Vance, Eden R. Martin	2010	370
2	Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proceedings of the National Academy of Sciences ·B.L. Scott, Nicolás G. Bazán	1989	365
3	Pesticide exposure and risk of Parkinson's disease: A family-based case-control study BMC Neurology ·Dana B. Hancock, Eden R. Martin, Gregory M. Mayhew, Jeffrey M. Stajich, Rita Jewett, Mark Stacy, B.L. Scott, Jeffery M. Vance, William K. Scott	2008	215
4	Expression Profiling of Substantia Nigra in Parkinson Disease, Progressive Supranuclear Palsy, and Frontotemporal Dementia With Parkinsonism Archives of Neurology ·Michael A. Hauser, Yi‐Ju Li, Hong Xu, Maher Noureddine, Yujun S. Shao, Steven R. Gullans, Clemens R. Scherzer, Roderick V. Jensen, Adam C. McLaurin, Jason Gibson, B.L. Scott, Rita Jewett, Judith E. Stenger, Donald E. Schmechel, Christine M. Hulette, Jeffery M. Vance	2005	129
5	Delayed-onset progressive movement disorders after static brain lesions Neurology ·B.L. Scott, Joseph Jankovic	1996	125
6	Fibroblast Growth Factor 20 Polymorphisms and Haplotypes Strongly Influence Risk of Parkinson Disease The American Journal of Human Genetics ·Joelle M. van der Walt, Maher Noureddine, Raja Kittappa, Michael A. Hauser, William K. Scott, Ron McKay, Fengyu Zhang, Jeffrey M. Stajich, Kenichiro Fujiwara, B.L. Scott, Margaret A. Pericak‐Vance, Jeffery M. Vance, Eden R. Martin	2004	106
7	Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease JAMA Ophthalmology ·Cason B. Robbins, Atalie C. Thompson, Paramjit K. Bhullar, Hui Yan Koo, Rupesh Agrawal, Srinath Soundararajan, Stephen P. Yoon, Bryce W. Polascik, B.L. Scott, Dilraj S. Grewal, Sharon Fekrat	2020	106
8	Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study Current Medical Research and Opinion ·Fabrizio Stocchi, Bonnie Hersh, B.L. Scott, Paul A. Nausieda, Luigi Giorgi, (unknown)	2008	86
9	Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease Archives of Neurology ·Dana B. Hancock, Eden R. Martin, Jeffrey M. Stajich, Rita Jewett, Mark Stacy, B.L. Scott, Jeffery M. Vance, William K. Scott	2007	85
10	Two-dimensional rhodopsin crystals from disk membranes of frog retinal rod outer segments. Proceedings of the National Academy of Sciences ·Joseph M. Corless, Darrell R. McCaslin, B.L. Scott	1982	60
11	Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in usher's syndrome Biochemical and Biophysical Research Communications ·Nicolás G. Bazán, B.L. Scott, T. Sanjeeva Reddy, Mary Z. Pelias	1986	60
12	Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome Movement Disorders ·B.L. Scott, Joseph Jankovic, Donald T. Donovan	1996	50
13	Family-based case-control study of cigarette smoking and Parkinson disease Neurology ·William K. Scott, Fengyu Zhang, Jeffrey M. Stajich, B.L. Scott, Mark Stacy, Jeffery M. Vance	2005	46
14	Patient preferences and utilities for ‘off-time’ outcomes in the treatment of Parkinson's disease Quality of Life Research ·Cynthia S. Palmer, Jordana K. Schmier, Edward H. Snyder, B.L. Scott	2000	45
15	Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses. PubMed ·Nicolás G. Bazán, B.L. Scott	1990	42
16	Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra Movement Disorders ·Maher Noureddine, Yi‐Ju Li, Joelle M. van der Walt, Robert Walters, Rita Jewett, Hong Xu, Tianyuan Wang, Jeffrey W. Walter, B.L. Scott, Christine Hulette, Don Schmechel, Judith E. Stenger, Fred S. Dietrich, Jeffery M. Vance, Michael A. Hauser	2005	38
17	NOS2A and the modulating effect of cigarette smoking in Parkinson's disease Annals of Neurology ·Dana B. Hancock, Eden R. Martin, Kenichiro Fujiwara, Mark Stacy, B.L. Scott, Jeffrey M. Stajich, Rita Jewett, Yi‐Ju Li, Michael A. Hauser, Jeffery M. Vance, William K. Scott	2006	29
18	Developing rod photoreceptors from normal and mutant Rd mouse retinas: Altered fatty acid composition early in development of the mutant Journal of Neuroscience Research ·B.L. Scott, Elisabeth Racz, Richard N. Lolley, Nicolás G. Bazán	1988	28
19	Impulse Control Disorders Arising in 3 Patients Treated With Rotigotine Clinical Neuropharmacology ·Thomas S. Wingo, Marian L. Evatt, B.L. Scott, Alan Freeman, Mark Stacy	2008	24
20	Identifying Peripapillary Radial Capillary Plexus Alterations in Parkinson’s Disease Using OCT Angiography Ophthalmology Retina ·Cason B. Robbins, Dilraj S. Grewal, Atalie C. Thompson, Srinath Soundararajan, Stephen P. Yoon, Bryce W. Polascik, B.L. Scott, Sharon Fekrat	2021	23

About B.L. Scott

B.L. Scott is a scholar working on Neurology, Cellular and Molecular Neuroscience, Molecular Biology, Ophthalmology and Clinical Psychology, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological disorders and treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (9 papers), Genetic Neurodegenerative Diseases (7 papers), Retinal Development and Disorders (6 papers), Fatty Acid Research and Health (5 papers), Retinal Diseases and Treatments (5 papers) and Obsessive-Compulsive Spectrum Disorders (4 papers). The work is most often cited by research in Neurology (1.0k citations), Neurology (273 citations), Cellular and Molecular Neuroscience (543 citations), Nutrition and Dietetics (340 citations) and Biochemistry (152 citations). B.L. Scott has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Nicolás G. Bazán, Jeffery M. Vance, Joseph Jankovic, Jeffrey M. Stajich, William K. Scott, Eden R. Martin, Mark Stacy, Dana B. Hancock, Gregory M. Mayhew and Michael A. Hauser. Their work appears in journals such as Movement Disorders, Neurology, Proceedings of the National Academy of Sciences, Translational Vision Science & Technology and Ophthalmology Retina.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact